Carpenter Delesha, Gonzalez Daniel, Retsch-Bogart George, Sleath Betsy, Wilfond Benjamin
Division of Pharmaceutical Outcomes and Policy,
Division of Pharmacotherapy and Experimental Therapeutics.
Pediatrics. 2017 Sep;140(3). doi: 10.1542/peds.2017-0195. Epub 2017 Aug 4.
In May 2016, the Eshelman School of Pharmacy at The University of North Carolina at Chapel Hill convened the PharmSci conference to address the topic of "methodological and ethical issues in pediatric medication safety research." A multidisciplinary group of experts representing a diverse array of perspectives, including those of the US Food and Drug Administration, children's hospitals, and academia, identified important considerations for pediatric medication safety research and opportunities to advance the field. This executive summary describes current challenges that clinicians and researchers encounter related to pediatric medication safety research and identifies innovative and ethically sound methodologies to address these challenges to improve children's health. This article addresses 5 areas: (1) pediatric drug development and drug trials; (2) conducting comparative effectiveness research in pediatric populations; (3) child and parent engagement on study teams; (4) improving communication with children and parents; and (5) assessing child-reported outcomes and adverse drug events.
2016年5月,北卡罗来纳大学教堂山分校的埃谢尔曼药学院召开了药学科学会议,讨论“儿科用药安全研究中的方法学和伦理问题”这一主题。一个由代表各种不同观点的多学科专家组成的小组,包括来自美国食品药品监督管理局、儿童医院和学术界的专家,确定了儿科用药安全研究的重要考量因素以及推动该领域发展的机会。本执行摘要描述了临床医生和研究人员在儿科用药安全研究方面遇到的当前挑战,并确定了创新且符合伦理的方法来应对这些挑战,以改善儿童健康。本文涉及五个领域:(1)儿科药物研发与药物试验;(2)在儿科人群中开展比较疗效研究;(3)儿童和家长参与研究团队;(4)改善与儿童和家长的沟通;(5)评估儿童报告的结果和药物不良事件。